Physician profile
Benjamin Baker
NPI 1104365188
$2,970.00
in general payments reported to CMS, 2019-2025
8 companies · $2,761 in 2025
The $2,761 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.74 · 2023: $184 · 2025: $2,761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982 · Travel and Lodging: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,981.52 |
| Travel and Lodging | $963.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $2,139.94 | 2025 | Tulsa-Pro |
| Medtronic, INC. | $208.86 | 2022-2023 | Interstim |
| Janssen Scientific Affairs, LLC | $129.00 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $127.75 | 2025 | |
| Photocure INC | $125.82 | 2025 | Cysview |
| Sumitomo Pharma America, INC. | $125.00 | 2025 | Orgovyx |
| Astellas Pharma US INC | $85.70 | 2025 | Xtandi |
| Janssen Biotech, INC. | $27.93 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.